Download
s00406-021-01335-y.pdf 326,61KB
WeightNameValue
1000 Titel
  • Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
1000 Autor/in
  1. Leucht, Stefan |
  2. Huhn, Maximilian |
  3. Davis, John M. |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-29
1000 Erschienen in
1000 Quellenangabe
  • 271(8):1411-1413
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00406-021-01335-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563551/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Depression affects around 320 million people worldwide. Growing evidence proposes the immune system to be the core interface between psychosocial stress and the neurobiological and behavioural features of depression. Many studies have identified purinergic signalling via the P2X7 receptor (P2X7R) to be of great importance in depression genesis yet only a few have evaluated P2X7R antagonists in chronic stress-based depression models. This review summarizes their findings and analyses their methodology. The four available studies used three to nine weeks of unpredictable, chronic mild stress or unpredictable, chronic stress in male mice or rats. Stress paradigm composition varied moderately, with stimuli being primarily psychophysical rather than psychosocial. Behavioural testing was performed during or after the last week of stress application and resulted in depressive-like behaviours, immune changes (NLRP3 assembly, interleukin-1β level increase, microglia activation) and neuroplasticity impairment. During the second half of each stress paradigm, a P2X7R antagonist (Brilliant Blue G, A-438079, A-804598) was applied. Studies differed with regard to antagonist dosage and application timing. Nonetheless, all treatments attenuated the stress-induced neurobiological changes and depressive-like behaviours. The evidence at hand underpins the importance of P2X7R signalling in chronic stress and depression. However, improvements in study planning and reporting are necessary to minimize experimental bias and increase data purview. To achieve this, we propose adherence to the Research Domain Criteria and the STRANGE framework.
1000 Sacherschließung
lokal Antipsychotic Agents/therapeutic use [MeSH]
lokal Humans [MeSH]
lokal Psychiatry
lokal Schizophrenia/drug therapy [MeSH]
lokal Neurosciences
lokal Editorial
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TGV1Y2h0LCBTdGVmYW4=|https://frl.publisso.de/adhoc/uri/SHVobiwgTWF4aW1pbGlhbg==|https://frl.publisso.de/adhoc/uri/RGF2aXMsIEpvaG4gTS4=
1000 Hinweis
  • DeepGreen-ID: 4503651b6bca408f8c7d528d686430fa ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6447236.rdf
1000 Erstellt am 2023-04-28T15:29:07.764+0200
1000 Erstellt von 322
1000 beschreibt frl:6447236
1000 Zuletzt bearbeitet 2023-10-14T13:35:25.641+0200
1000 Objekt bearb. Sat Oct 14 13:35:25 CEST 2023
1000 Vgl. frl:6447236
1000 Oai Id
  1. oai:frl.publisso.de:frl:6447236 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source